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Murine antibody responses to soluble proteins and to carbohydrates are
generally restricted to the IgGI and IgG3 subclasses, respectively (1-7), suggest-
ing that IgG isotypes are not selected at random. Surprisingly, no family of
antigens has been shown to preferentially induce the production of IgG2a
antibodies, although this subclass represents a major component ofmouse serum
immunoglobulins (8). A few recent observations nevertheless suggested that
IgG2a could predominate in antiviral antibody responses (9-12). This isotypic
bias was particularly striking afterinfection with lactate dehydrogenase-elevating
virus (LDV)t and lymphocytic choriomeningitis virus (LCMV). However, because
these twoviruses induce considerable alterations ofthe immunesystem, including
a polyclonal B lymphocyte activation (13, 14), they mayevokeantibody responses
that are not representative of more common antiviral reactions.
To examine whether IgG2a restriction is a general property of marine anti-
body responses to viral antigens, we analyzed the isotypic profile of antibodies
directed against a panel of both DNA and RNA mouse viruses, representative
ofwidely different genera . Our data demonstrate that all viral infections intro-
duce a unique bias in the subclass selection process that makes IgG2a the
predominant antiviral IgG antibody in the mouse.
Materials and Methods
Mice. CBA/Rij and 129/Sv mice were bred at The Ludwig Institute for Cancer
Research, and C57BL/6 mice were purchased from TNO (REPGO Institute TNO,
Rijswijk, The Netherlands). Mice were maintained in specific pathogen-free conditions
and used when 6-10 weeks old.
Viruses.
￿
Infections were performed by theintranasal route with serial dosesofa panel
ofviruses, including mouse adenovirus (FL strain), polyomavirus (LID-1 strain), reovirus
type 3 (Abney strain), sindbis virus (Ar-339 strain), mouse hepatitis virus (MHV; A59
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LDV, lactate dehydrogenase-elevating virus; LCMV, lympho-
cytic choriomeningitis virus; MHV, mouse hepatitis virus; PVM, pneumonia virus of mice; TMEV,
Theiler's mouse encephalomyelitis virus.
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strain), Sendai virus, pneumonia virus of mice (PVM; strain 15), LCMV (WE3 strain),
Theiler's mouse encephalomyelitis virus (TMEV; GDVII strain), and Mengo virus (C50L
strain), or by the intraperitoneal route with LDV (Riley strain).
Antigens.
￿
Mice were immunized by intraperitoneal injection without adjuvant of 100
jig of chicken immunoglobulin (a gift of Dr. J. P. Vaerman, Universite Catholique de
Louvrain), human lactoferrin (15), horse ferritin (Boehringer Mannheim, Mannheim,
Federal Republic of Germany), bovine fibrinogen (Calbiochem-Behring Corp., La Jolla,
CA), tetanus toxoid (Wellcome Reagents Limited, London, England), human thyroglob-
ulin (a gift of Dr. P. De Nayer, Universite Catholique de Louvrain), bromelain (Calbi-
ochem-Behring Corp.), human IgE (a gift of Dr. J. M. Saint-Remy, Universite Catholique
de Louvrain), keyhole limpet hemocyanin (KLH) Calbiochem-Behring Corp.)), or human
transferrin (Behringwerke, AG, Marburg/Lahn, Federal Republic of Germany).
ELISA.
￿
IgG antibody subclasses were determined in sera by ELISA as described by
Coutelier et al. (10). Briefly, polystyrene plates (439454; Nunc, Roskilde, Denmark; or
655101 ; Greiner, Nurtingen, Federal Republic of Germany) were coated overnight with
pelleted viruses or with purified proteins, and incubated with serial dilutions of sera.
Binding of antibodies was measured with rabbit antisera specific for each mouse IgG
subclass followed by peroxidase-conjugated goat anti-rabbit IgG antibodies, or, for
C57BL/6, IgG2a, with an allotype-specific monoclonal antibody of BALB/c origin .
Results, expressed in micrograms per milliliter, were calculated on standard curves of
selected anti-DNP monoclonal antibodies (10).
Results and Discussion
The subclass distribution of serum IgG antibodies wasanalyzed after infection
of mice with a panel of both DNA and RNA viruses, representative of eleven
different genera. For comparison, animals were also immunized with a number
of soluble protein antigens. These two groups of antigens elicited specific
antibody responses that differed markedly in their isotypic profiles. As a rule,
viruses induced much more IgG2a than IgGI antibodies, while the converse was
observed with soluble proteins. This wasbest illustrated by the IgG2a/IgGI ratio
shown in Fig. 1. Somewhat surprisingly in view of the heterogeneity of the
viruses used in our experiments, the predominance of IgG2a antibodies was
consistent, rangingfrom 65 to 92% of totalantiviral IgG in CBA/Rij mice (Table
1) . In particular, it wasnot significantly affected either by thepresence or absence
of a viral envelope or by the DNA or RNA nature of the viral nucleic acids.
Moreover, it remained relatively constant with time (data not shown) and was
not changed after a secondary infection (Table 1I). The possibility that this
restriction could be due to the intranasal route used for virus inoculation was
also excluded by the finding that intraperitoneal injection of adenovirus elicited
a similar IgG2a-restricted response (Fig. 2).
In contrast, IgGI, IgG2b, and IgG3 antibodies showed greater relative varia-
tions. For example, virtually no IgGI antibodies were detectable against poly-
omavirus or sindbis virus, whereas they represented ^-20% of the antibody
response against Sendai virus. These differences were reproducible from one
experiment to another, which suggests that each viral species elicits an antibody
response with a characteristic isotypic profile.
The isotypic pattern of antiviral antibodies varied little in the three strains of
mice tested (129/Sv, CBA/Rij, and C57BL/6). However, after infection with
certain viruses, such as TMEV and PVM, C57BL/6 produced much less IgG2a






























IgG2a/IgGI ratio ofantiviral andantiprotein antibodies. Sera from 129/Sv mice
were collected 6-7 wk after infection or 3-6 wk after immunization with soluble proteins.
Results are expressed as log mean ± SE of individual IgG2a/ IgGI ratios for antiviral (open
bars) and antiprotein (closed bars) antibodies. The broken line indicates the minimal
IgG2a/IgG1 ratio for mice where no IgGI could be measured.
TABLE I
Isotypic Distribution ofAntiviralIgG Antibodies in CBA/Rij Mice
Results are expressed in percent total antiviral IgG (sum of the four subclasses), mean ± SE. 7-17
mice/group were tested 21 d after infection.
with previous analyses of anti-LDV (10) and antioxazolone (16) antibodies, could
be related to the Igh-C allotype of the mice.
The unusual isotypic profile of antiviral antibodies could either be due to
certain common biochemical properties of viral antigens, such as the presence of
repetitive determinants, or be related to the viral infection itself. Preliminary
results indicated that, in some cases, a concomitant infection could modify the
Virus IgGI IgG2a IgG2b IgG3
Adeno 2.3±0.3 91 .6±0.6 4.4±0.4 1.6±0.2
Polyoma <0.2 83.0 ± 2.2 9.9 ± 1.9 7.1 ± 1.4
Reo 3 <0.3 86.8 ± 1.2 12 .5 ± 1.2 <0.4
Sindbis 0.8 ± 0.1 90.3 ± 1.0 7.7 ± 0.8 1.3 ± 0.2
LDV 3.0±1 .1 74.6±3.3 13.0±2.3 9.4±2.1
MHV 7.9±2.8 79.0±1 .6 10.4±1.1 2.7±0.5
Sendai 17.6±4.8 75.3±6.3 6.7±1.5 0.4±0.1
PVM 13.0±3.0 66.1±4.4 15.6±1 .9 5.3±2.5
LCMV 10.1±1 .7 86.6±1 .8 3.1±0.3 0.4±0.1
TMEV 12.4±2.2 65.9±3.6 19.4±3.6 2.4±0.3
Mengo <5 .2 71 .2 ± 5.1 18.8 ± 3.9 <4.8Isotypic Profile ofAnti-TMEVAntibodies after SecondaryInfection
* CBA/Rij mice (3-4 mice/group) were reinfected with TMEV 7 wk aftera primaryinfection .
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FIGURE 2.
￿
Isotypic distribution of antiadenovirus antibodies after intraperitoneal infection .
Sera were collected 3 wk afterintraperitoneal infection of 129/Sv mice. Results areexpressed
as percent total IgG response, (mean ± SE, n = 20).
TABLE III
Isotypic Distribution ofAntiviral IgG Antibodies in C57BL/6 Mice
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Results are expressed as percent total antiviral IgG (sum of the four subclasses), mean ± SE. 9-18
mice/group were tested 21 d after infection.
isotypic distribution of the antibody response against inactivated virus, which
supports the latter hypothesis. Analysis of the mechanisms involved in this
phenomenon could provide a new approach to the study of isotype selection.
IgG2aantibodies have been shown (17-19) to display functional characteristics
different from IgG1 immunoglobulins, in particular with regard to complement
activation. Thepredominance ofthis subclass after viral infection could therefore
correspond to the selection of a more efficacious response to the virus. If this
proved to be true, this observation would have major implications in the devel-
opment ofappropriate vaccination schemes.
Summary
The isotypic distribution of IgG antibodies was determined in the serum of
mice after infection with a panel of RNA and DNA viruses representative of I 1
Virus IgGI IgG2a IgG2b IgG3
Adeno 0.3±0.1 85.4±0.7 11 .8±0.7 2.5±0.2
Sendai 11 .1 ± 1.4 73.4 ± 2.2 14.7 ± 1.1 0.8 ± 0.1
PVM 33.9±3.8 33.2±3.4 19.5±2.8 13.5±2.7
LCMV 2.8 ± 0.7 81 .8 ± 1.8 12.9 ± 0.9 2.6 ± 1.0
TMEV 6.5±2.4 57.6±4.8 34.7±3.1 1.3±0.1










-1 1.9±0.3 23.7±5 .4 68.1±6.2 6.9±0.8 1.3±0.3
8 1.7±0.3 13.9±2 .5 73.7±2.7 11 .5±1 .2 1.0±0.2
49 3.5±0.2 11 .1±0.6 84.0±1.0 4.5±1 .6 0.4±0.268
￿
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different genera. The antiviral response induced by all these viruses showed a
striking preponderance of the IgG2a subclass whatever the strain of mice tested
or the time elapsed after infection. Together with the predominance of IgG 1 in
antiprotein and of IgG3 in anticarbohydrate responses, this IgG2a restriction of
antiviral antibodies strongly suggests the existence of highly specific mechanisms
for the regulation of individual subclasses in the mouse.
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